Literature DB >> 8247209

Interaction between cyclosporin and chloroquine.

P Finielz, Z Gendoo, C Chuet, J Guiserix.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8247209     DOI： 10.1159/000187506

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  9 in total

Review 1.  Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine.

Authors:  Mariana Babayeva; Zvi Loewy
Journal:  Pharmgenomics Pers Med       Date:  2020-10-23

Review 2.  Antimalarials - old drugs are new again.

Authors:  Anna Woźniacka
Journal:  Postepy Dermatol Alergol       Date:  2021-08-11       Impact factor: 1.664

Review 3.  Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy.

Authors:  R Matthew Chico; Daniel Chandramohan
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-07-07       Impact factor: 4.481

Review 4.  Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.

Authors:  Laure Elens; Loralie J Langman; Dennis A Hesselink; Stein Bergan; Dirk Jan A R Moes; Mariadelfina Molinaro; Raman Venkataramanan; Florian Lemaitre
Journal:  Ther Drug Monit       Date:  2020-06       Impact factor: 3.681

Review 5.  Drug-drug interactions with candidate medications used for COVID-19 treatment: An overview.

Authors:  Haleh Rezaee; Fariba Pourkarim; Samira Pourtaghi-Anvarian; Taher Entezari-Maleki; Touraj Asvadi-Kermani; Masoud Nouri-Vaskeh
Journal:  Pharmacol Res Perspect       Date:  2021-02

Review 6.  Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties.

Authors:  Cornelis Smit; Mariska Y M Peeters; John N van den Anker; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2020-06       Impact factor: 6.447

Review 7.  American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in the United States.

Authors:  Zahra Mahmoudjafari; Maurice Alexander; Julianna Roddy; Ryan Shaw; Terri Lynn Shigle; Colleen Timlin; Katie Culos
Journal:  Biol Blood Marrow Transplant       Date:  2020-04-17       Impact factor: 5.742

8.  Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics.

Authors:  Soufian Meziyerh; Tom C Zwart; Ronald W van Etten; Jeroen A Janson; Teun van Gelder; Ian P J Alwayn; Johan W de Fijter; Marlies E J Reinders; Dirk J A R Moes; Aiko P J de Vries
Journal:  Am J Transplant       Date:  2020-05-13       Impact factor: 9.369

Review 9.  Antivirals for COVID-19 in Solid Organ Transplant Recipients.

Authors:  Justin C Laracy; Elizabeth C Verna; Marcus R Pereira
Journal:  Curr Transplant Rep       Date:  2020-10-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.